Cinchonine hydrochloride is used as an inhibitor of multidrug resistance (MDR) phenomenon; it can be formulated into pharmaceutical compositions for the treatment of MDR-associated cancers; it serves as an antispasmodic agent for the treatment of arrhythmias when resistance to conventional drugs occurs; it is also used in the treatment of malaria; additionally, it activates endoplasmic reticulum stress to induce apoptosis in human hepatocellular carcinoma cells.